Kirk Williamson

VT GMCB Affordability and Pricing Director. NH PDAB, Arnold Ventures, Duke-Margolis, and NGA alum.

[Kirk Williamson @kirkbwilliamson]

https://t.co/h1kFFZuGNG

[Donald M. Kreis @DMoKreis]

To my fellow Granite Staters: Please help me save the Prescription Drug Affordability Board! As a cystic fibrosis dad, I fear for my daughter's future when her annual pharmacy bill is north of $400k. https://t.co/ro6P12P3T3

[Donald M. Kreis @DMoKreis]

Here's the state of play when it comes to Prescription Drug Affordability Boards around the US. Don't let NH fall behind! Granite staters, write your state senator. https://t.co/64UPuHEBeH

[NH Bulletin || bsky @nhbulletinnews.bsky.social @NHBulletinNews]

"New Hampshire is one of 11 states with a Prescription Drug Affordability Board, and the latest annual report illustrates why we are lucky to have such a body." Commentary from state Consumer Advocate Donald Kreis. https://t.co/rJCVKW0oNN

[Donald M. Kreis @DMoKreis]

Finally, with all due respect to my friends at the @CF_Foundation this excellent report from the NH PDAB shows why Prescription Drug Affordability Boards are good public policy. The CFF should stop acting like PDABs are part of the problem. They are part of the solution! 10/10

[Donald M. Kreis @DMoKreis]

🧵Not-so-trivial trivia question: What is New Hampshire's most expensive prescription drug? 1/10

[Sarah Karlin-Smith @SarahKarlin]

New drugs were slower to gain reimbursement in the US than those approved in Switzerland & Germany, even though the drugs undergo health technology assessments and price negotiation before they are reimbursed in those countries, a new analysis found.
https://t.co/Irjgfl4v3L

[Daniel G. Aaron, MD, JD @MedlawDan]

Unfortunately my family has gotten unlucky with new innovations. That, or there is something wrong with many products under FDA oversight.

We should be careful about what we lose when we define innovation as earlier access. I discuss this at length here:
https://t.co/U4uGffIqSz

[Kirk Williamson @kirkbwilliamson]

"official acts" are yesterday's "march in rights"

[Sarah Karlin-Smith @SarahKarlin]

Like drug shortages and trial diversity this has been an issue at least as long as I have been covering drug development and feels like very little progress has been made as people have same convos over and over.

[Elaine Chen @elaineywchen]

To treat obesity in children, the US Preventive Services Task Force favors behavioral therapy over drugs like Wegovy, via @cooney_liz
https://t.co/zvedYOfjMq

[Liz Szabo @LizSzabo]

This boot camp on medical evidence made me the journalist I am today. Super useful, free and fun. Apply now. Spread the word! @ahcj @NABJ @NAHJ @aaja @naja @ScienceWriters @sejorg
https://t.co/2YCw0E4XLN

[JAMA Health Forum @JAMAHealthForum]

Prices for specialty drugs have continued to increase over time in the Medicare Part D program, which contributes to high out-of-pocket liability for users of those drugs in addition to US federal budgetary expenditures. https://t.co/BxZ8gBYx8a @hayfordtamara

[Zach Brennan @ZacharyBrennan]

FDA approves the first two interchangeable biosimilars to $REGN's Eylea -- and doesn't require switching studies as part of the approvals https://t.co/c7CYBDief6

[William Feldman @wbfeldman]

I’ll be testifying next week before the Senate Judiciary Committee on pharmaceutical patents and pricing. 10 AM on Tuesday, May 21. You can tune in here! Thank you to @SenatorDurbin and the committee for the opportunity to share my thoughts.

https://t.co/LywGyAAGnV

[Reshma Ramachandran @reshmagar]

Incredible closing keynote from Dr. @fumikochino at the @PittCP3 #Pharmacoequity conference on the many, many downstream & devastating impacts on patients of financial toxicity, noting that "disparities drive financial toxicity & financial toxicity drives disparities."

[Kirk Williamson @kirkbwilliamson]

It's always worth listening to @realtahiramin - but the real star is NH's very own @Maggie_Hassan standing up to protect Granite Staters' access to affordable prescription drugs 👏

[Initiative for Medicines, Access & Knowledge @IMAKglobal]

📺WATCH: @realtahiramin unpacks how Bristol Myers Squibb amassed dozens of additional patents on its top-selling drug Eliquis, then weaponized those patents to sue competitors and prevent them from entering the U.S. market.

[Cindy Rosenwald @CindyR4NH]

I'm proud to be a member of the Prescription Drug Affordability Board. Medications don't work when they're so expensive they're unaffordable. @NHSenateDems #NHPolitics

[Kirk Williamson @kirkbwilliamson]

The New Hampshire Prescription Drug Affordability Board Announces Local and State Leaders of the Inaugural Stakeholder Advisory Council to Lower Prescription Drug Costs

https://t.co/Sbavs7oU1n